Remedium Technologies, Inc.

387 Technology Dr.
College Park, MD 20742

SBIR Award Summary

Total Number of Awards 2
Total Value of Awards $650K
First Award Date 01/01/12
Most Recent Award Date 01/01/13

Key Personnel

Last Name Name Awards Contact
Dowling Matthew B. Dowling 4 Message

2 Awards Won

Phase 2 SBIR

Agency: National Science Foundation
Topic: BC-2012
Budget: 01/01/13 - 12/31/13

This Small Business Innovation Research (SBIR) Phase II project aims to develop a sprayable foam hemostat for treatment of non-compressible hemorrhage, which is the leading cause of death (~90%) for bleeding-related trauma. The foam material is based on the biopolymer chitosan; a modification to this polymer with novel hydrophobic grafts allows ...

Phase 1 SBIR

Agency: National Science Foundation
Topic: BC-2012
Budget: 01/01/12 - 12/31/12

This Small Business Innovation Research (SBIR) Phase I project aims to develop a sprayable "reversible" foam hemostat for treatment of non-compressible hemorrhage, which is the leading cause of death (~90%) for bleeding-related trauma. The foam material is based on the biopolymer chitosan; a modification to this polymer with novel hydrophobic gr...